Refeyn

Refeyn will continue its role in a project that has received additional funding through the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), focused on intelligent optimization of adeno-associated virus (AAV) purification pr

Paul C. Collins Director of Research at Purdue University Refeyn is pleased to announce that Paul C. Collins has joined its Scientific Advisory Board (SAB). Paul brings a wealth of experience spanning synthetic small molecules, monoclonal antibodies, ther

New integrated workflow combines icIEF fractionation and mass photometry Enables simultaneous assessment of charge and size variants at single molecule resolution Four-hour workflow reduces development risk and accelerates biosimilar manufacturing MINNEAP

Compact, all-in-one mass photometer helps researchers verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR, and other costly experimentsOXFORD, United Kingdom, March 18, 2026 (GLOBE NEWSWIRE) -- Refeyn, developer of pioneering mass phot

The MyMass mass photometer enables researchers to quickly verify sample quality before proceeding to cryo-EM, native MS, BLI, SPR and other demanding experimental workflows. Compact, all-in-one mass photometer helps researchers verify sample quality befor

Refeyn launches MyMass - an all-in-one mass photometer for fast, accurate sample quality assessment ahead of costly structural biology workflows....

As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability Refeyn's Samux benchtop mass photometer enables rapid analysis of adeno-associated viru

This post was first published in March 2023 Updated on 20 February 2026 Adeno-associated virus (AAV) sample characterization is critical for research, development, and manufacturing processes of gene therapies that involve these viral vectors (Fig. 1). At